Incidence and survival estimates for patients with myelodysplastic syndrome in the early 21st century: no evidence of improvement over time-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence and survival estimates for patients with myelodysplastic syndrome in the early 21st century: no evidence of improvement over time

Published:2022-03-27 Issue:8 Volume:63 Page:1964-1969
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Pulte Dianne¹,Jansen Lina¹,Brenner Hermann¹²³

Affiliation:

1. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DFKZ), Heidelberg, Germany

2. Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany

3. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany

Funder

German Cancer Aid

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2053529

Reference27 articles.

1. Medical Conditions and Modifiable Risk Factors for Myelodysplastic Syndrome: A Systematic Review

2. Revised International Prognostic Scoring System for Myelodysplastic Syndromes

3. New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

4. Treatment of MDS

5. Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling sex-based geographical disparities in myelodysplastic syndrome mortality trends in Spain (1999–2022);Clinical and Translational Oncology;2024-05-19

2. Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges;Frontiers in Bioscience-Landmark;2024-02-22

3. Myelodysplastic syndromes mortality in Spain: a comprehensive age-period-cohort and joinpoint analysis;Clinical and Translational Oncology;2023-09-28

4. Epidemiological Trends of Haematological Malignancies in Belgium 2004–2018: Older Patients Show the Greatest Improvement in Survival;Cancers;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3